Incidence of nonmelanoma skin cancer in New Brunswick, Canada, 1992 to 2001

Journal of Cutaneous Medicine and Surgery

Volumn 11, Issue 2, 2007, Pages 45-52

  Hayes, Robert C ^a,b,c   Leonfellner, Suzanne ^a,b,c   Pilgrim, Wilfred ^a,b,c   Liu, Jian ^a,b,c   Keeling, Douglas N ^a,b,c  

^a Atlantic Health Sciences Corporation   (Canada)

^b Provincial Epidemiology Service   (Canada)

^c BROCK UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BASAL CELL CARCINOMA; CANADA; CANCER INCIDENCE; CANCER INVASION; CANCER LOCALIZATION; CANCER REGISTRY; CONTROLLED STUDY; FEMALE; HUMAN; LIFESPAN; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROBABILITY; SEX DIFFERENCE; SKIN CANCER; SQUAMOUS CELL CARCINOMA; TREND STUDY; ADOLESCENT; FACE TUMOR; INCIDENCE; MIDDLE AGED; REGISTER; SKIN TUMOR;

ADOLESCENT; ADULT; AGED; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FACIAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEW BRUNSWICK; REGISTRIES; SKIN NEOPLASMS;

EID: 34347213035     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.2310/7750.2007.00010     Document Type: Article

References (59)

1. Scotto J, Fears TR, Fraumeni JF. Incidence of nonmelanoma skin cancer in the United States. Washington (DC): Public Health Service; 1983. NIH Publication No.: 83-2433.
2. Marks R, Staples M, Giles CG. Trends in non-melanocytic skin cancer treated in Australia: the second national survey. Int J Cancer 1993;53:585-90.
3. Weinstock MA. The epidemic of squamous cell carcinoma. JAMA 1989;262:2138-40.
4. Gloster H, Brodland D. The epidemiology of skin cancer. Dermatol Surg 1996;22:217-26.
5. Tran H, Chen K, Shumak S. Epidemiology and aetiology of basal cell carcinoma. Br J Dermatol 2003;149 Suppl 66:50-2.
6. Diepgen TL, Mahler VM. The epidemiology of skin cancer. Br J Dermatol 2002;146 Suppl 61:1-6.
7. Gallagher RP, Lee T. Assessing incidence trends in nonmelanocytic skin cancer: which method is best? J Cutan Med Surg 1998;3:35-9.
8. Statistics Canada. 2001 census. Available at: http://www12.statcan.ca/ english/census01/products/standard/popdwell/Table-PR.cfm. (accessed April 7, 2004).
9. Gallagher RP, Ma BM, McLean DI, et al. Trends in basal cell carcinoma, squamous cell carcinoma, and melanoma of the skin from 1973 through 1987. J Am Acad Dermatol 1990;23:413-21.
10. Coebergh JWW, Neumann HAM, Vrints LW, et al. Trends in the incidence of non-melanoma skin cancer in the SE Netherlands 1975-1988: a registry-based study. Br J Dermatol 1991;125:353-9.
11. Fay MP, Pfeifer R, Cronin KA, et al. Age-conditional probabilities of developing cancer. Stat Med 2003;22:1837-48.
12. Demers AA, Nugent Z, Mihalcioiu C, et al. Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population. J Am Acad Dermatol 2005;53:320-8.
13. Buettner PG, Raasch BA. Incidence rates of skin cancer in Townsville, Australia. In J Cancer 1998;78:587-93.
14. Koh D, Wand H, Lee J, et al. Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin: analysis of the Singapore cancer registry data 1968-97. Br J Dermatol 2003;148:1161-6.
15. Magnus K. The Nordic profile of skin cancer incidence: a comparative epidemiological study of the three main types of skin cancer. Int J Cancer 1991;47:12-9.
16. Iverson T, Tretli S. Trends for invasive squamous cell neoplasia of the skin in Norway. Br J Cancer 1999;81:528-31.
17. Wassberg C, Thorn M, Johannson AM, et al. Increasing incidence rates of squamous cell carcinoma of the skin in Sweden. Acta Derm Venereol 2001;81:268-72.
18. Stang A, Stegmaier C, Jockel K-H. Non-melanoma skin cancer in the federal state of Saarland, Germany, 1995-1999. Br J Cancer 2003;89:1205-8.
19. Hannuksela-Svahn A, Pukkala E, Karvonen J. Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995. Arch Dermatol 1999;135:781-6.
20. Katalinic A, Kunze U, Schafer T. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumor stages and localization (epidemiology of skin cancer). Br J Dermatol 2003;149:1200-6.
21. Boi S, Cristofolini M, Micciolo R, et al. Epidemiology of skin tumors: data from the cutaneous cancer registry in Trentino, Italy. J Cutan Med Surg 2003;7:300-5.
22. Levi F, Te VC, Randimbison L, et al. Trends in skin cancer in Vaud: an update, 1976-1998. Eur J Cancer Prev 2001;10:371-3.
23. Holme SA, Malinovsky K, Roberts DL. Changing trends in non-melanoma skin cancer in South Wales, 1988-98. Br J Dermatol 2000;143:1224-9.
24. Kaldor J, Shugg D, Young B, et al. Non-melanoma skin cancer: ten years of cancer-registry-based surveillance. Int J Cancer 1993;53: 866-91.
25. Chuang TY, Popescu A, Su WPD, Chute CG. Basal cell carcinoma: a population-based incidence study in Rochester, Minnesota. J Am Acad Dermatol 1990;22:413-7.
26. Chuang TY, Popescu A, Su WPD, Chute CG. Squamous ell carcinoma: a population-based incidence study in Rochester, Minn. Arch Dermatol 1990;126:185-8.
27. Karagas MR, Greenberg ER, Spencer SK, et al. Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. Int J Cancer 1999;81:555-9.
28. Glass AG, Hoover RN. The emerging epidemic of melanoma and squamous cell skin cancer. JAMA 1989;262:2097-100.
29. Gray DT, Suman VJ, Su WPD, et al. Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992. Arch Dermatol 1997;133:735-40.
30. Reizner GT, Chuang TY, Elpern DJ, et al. Basal cell carcinoma in Kauaii, Hawaii: the highest documented incidence in the United States. J Am Acad Dermatol 1993;29:184-9.
31. Harris RB, Griffith K, Moon TE. Trends in the incidence of nonmelanoma skin cancer in southeastern Arizona, 1985-1996. J Am Acad Dermatol 2001;45:528-36.
32. Staples M, Marks R, Giles G. Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs starting to have an effect? Int J Cancer 1998;78:144-8.
33. Raasch BA, Buettner PG. Multiple nonmelanoma skin cancer in an exposed Australian population. Int J Dermatol 2002;41:652-8.
34. Green A, Battistutta D, Hart V, et al. Skin cancer in a subtropical Australian population: incidence and lack of association with occupation. Am J Epidemiol 1996;144:1034-40.
35. English DR, Kricker A, Heenan PJ, et al. Incidence of non-melanocytic skin cancer in Geraldton, Western Australia. Int J Cancer 1997;73:629-33.
36. Roberts DL. Incidence of non-melanoma skin cancer in West Glamorgan, South Wales. Br J Dermatol 1990;122:399-403.
37. Stern RS. The mysteries of geographic variability in nonmelanoma skin cancer incidence. Arch Dermatol 1999;135:843-4.
38. Gallagher RP, Hill GB, Badjick CD, et al. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer: I. Basal cell carcinoma. Arch Dermatol 1995;131:157-63.
39. Wong CSM, Strange RC, Lear JT. Basal cell carcinoma. BMJ 2003; 327:794-8.
40. Vitasa BC, Taylor HR, Strickland PT, et al. Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen. Cancer 1990;65: 2811-7.
41. Stenbeck KD, Balanda KP, Williams MJ, et al. Patterns of treated non-melanoma skin cancer in Queensland - the region with the highest incidence rates in the world. Med J Aust 1990;153:511-5.
42. Strom S, Yamamura Y. Epidemiology of nonmelanoma skin cancer. Clin Plast Surg 1997;24:627-36.
43. Lucke TW, Hole DJ, Mackie RM. An audit of the completeness of non-melanoma skin cancer registration in Greater Glasgow. Br J Dermatol 1997;137:761-3.
44. Brewster DH, Crichton J, Harvey JC, et al. Benefits and limitations of pathology databases to cancer registries. J Clin Pathol 1996;49: 947-99.
45. Mikeljevic JS, Johnston C, Adamson PJ, et al. How complete has skin cancer registration been in the UK? A study from Yorkshire. Eur J Cancer Prev 2003;12:125-33.
46. Craven NM, Roberts DL. Skin cancer registration in the United Kingdom. Br J Dermatol 1994;131 Suppl 44:30-1.
47. McLoone NM, Middleton RJ, Gavin AT, et al. Audit of basal cell carcinoma: registration practice. Br J Dermatol 2003;148:363-84.
48. Giles GG, Marks R, Foley P. Incidence of non-melanoma skin cancer treated in Australia. BMJ 1988;296:13-7.
49. Marks R, Staples M, Giles GG. Trends in non-melanocytic skin cancer treated in Australia: the second national survey. Int J Cancer 1993;53:585-90.
50. Green A, Beardmore G, Hart V, et al. Skin cancer in a Queensland population. J Am Acad Dermatol 1988;19:1045-52.
51. Green A, Battistutta D. Incidence and determinants of skin cancer in a high risk Australian population. Int J Cancer 1990;46:356-61.
52. Kricker A, English DR, Randell PL, et al. Skin cancer in Geraldton, Western Australia: a survey of incidence. Med J Aust 1990;152:399-407.
53. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994;30:744-8.
54. Hoy WE. Nonmelanoma skin carcinoma in Albuquerque, New Mexico: experience of a major health care provider. Cancer 1996; 77:2489-95.
55. Marcil I, Stern RS. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol 2000; 136:1524-30.
56. Marks R, Jolley D, Dorevitch AP, Selwood TS. The incidence of non-melanocytic skin cancers in an Australian population: results of a five-year prospective study. Med J Aust 1989;150:475-8.
57. Marks R, Kopf AW. Healthy skin for all: cancer of the skin in the next century. Int J Dermatol 1995;34:445-7.
58. Marks R. Two decades of the public health approach to skin cancer control in Australia: why, how, and where are we now? Australas J Dermatol 1999;40:1-5.
59. Montague M, Borland R, Sinclair C. Slip! Slop! Slap! and SunSmart, 1980-2000: skin cancer control and 20 years of population-based campaigning. Health Educ Behav 2001;28:290-305.